Talk:Cefquinome

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Cefquinome.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

This page was part of the 1013 Project. It was originally created or significantly expanded by members of an introductory composition class at the University of Minnesota. Our work on this article ended on May 9, 2007, and we invite all Wikipedians to jump in with further expansion and revision. Be as BOLD in editing this article as you would any other Wikipedia article, but please be good about communicating your changes through edit summaries and talk pages. Students will check back on these articles in the coming months, and we can learn from the changes you make. For more information on the project, visit the project archive.

A fact from Cefquinome appeared on Wikipedia's Main Page in the Did you know column on 3 May 2007. The text of the entry was as follows:

Did you know... that cefquinome is an antibiotic developed to treat bovine respiratory disease?

A record of the entry may be seen at Wikipedia:Recent additions/2007/May.

Wikipedia

Usage[edit]

This sounds a little bit like a "how-to" section. It seems to me that there is nothing exceptional about handling injectable solutions / suspensions of this particular antibiotic. I suggest that most of the section be replaced with a link to this article for example, or simply remove it entirely. Cheers. Numero4 (talk) 07:50, 3 January 2010 (UTC)[reply]

Resistance and food-borne transmission[edit]

Once again, the information in this section could apply to most antibiotics, so to the reader, it may sound as if this is a particular feature of this drug. Also, it is mentioned in the opening section that Cefquinome is resistant to beta-lactamase, yet we read that overusage can lead to resistance due to amplification of beta-lactamase populations of bacteria. Cheers. Numero4 (talk) 07:58, 3 January 2010 (UTC)[reply]

External links modified[edit]

Hello fellow Wikipedians,

I have just modified 3 external links on Cefquinome. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 18 January 2022).

If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 17:10, 1 August 2017 (UTC)[reply]

"Cobactan®" listed at Redirects for discussion[edit]

An editor has identified a potential problem with the redirect Cobactan® and has thus listed it for discussion. This discussion will occur at Wikipedia:Redirects for discussion/Log/2022 April 15#Cobactan® until a consensus is reached, and readers of this page are welcome to contribute to the discussion. BD2412 T 04:45, 15 April 2022 (UTC)[reply]